Important Update on FDA Changes Concerning Peptides Big news for peptides! In July, the FDA will meet to evaluate the most commonly used peptides for FDA authorized compounding. Public Meeting: FDA Rare Disease Day 2026 02 23 2026 FDA DIHEXA PEPTIDE 10MG VIAL UMBRELLA Labs FDA Tracker for Cell and Gene Therapies in 2026 Alliance for Regenerative Medicine posted on the topic LinkedIn